Northwell Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwell Health sits in the top decile of US sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count).

370 total trials 81 currently recruiting 209 completed early-phase tilt top decile by trial count

Northwell Health: 370 sponsored US clinical trials, 81 recruiting.

Northwell Health sponsors 370 registered US clinical trials on ClinicalTrials.gov, 81 of them currently recruiting, and 209 completed. 38 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 8 trials.

Top-decile sponsor footprint

Northwell Health ranks in the top decile of sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 36/100

209 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

370 total, page 4 of 8

COMPLETED

Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol

NCT04476602

COMPLETED Phase 3

Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients

NCT04401293

COMPLETED NA

Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis

NCT03975400

COMPLETED Early Phase 1

Post-operative Complications and Graft Survival With Conventional Versus Continuous Glucose Monitoring in Patients With Diabetes Mellitus Undergoing Renal Transplantation

NCT04742023

COMPLETED Phase 3

Multi-site Adaptive Trials for COVID-19

NCT04370262

COMPLETED NA

Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin

NCT04533945

COMPLETED

Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation in Hypoxic COVID-19 Patients. Prospective Cohort Study.

NCT04407260

COMPLETED NA

Improving Decision-Making for Low Health Literate Prostate CA Patients

NCT05800483

COMPLETED NA

Reducing Behavioral and Psychological Symptoms of Dementia: Family Caregivers (Aim 1)

NCT04481568

COMPLETED NA

Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's Disease

NCT04184791

COMPLETED Early Phase 1

Dobutamine on the Cardiac Conduction System

NCT04249258

COMPLETED NA

Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage

NCT04126408

TERMINATED NA

Effect of Transcutaneous Electrical Auricular Stimulation of the Vagus Nerve in Kidney Transplant Recipients

NCT04256837

COMPLETED Early Phase 1

Basivertebral Nerve Block During Vertebral Augmentation: An Alternative Approach to Intraprocedural Pain Management

NCT04774029

COMPLETED Phase 2

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

NCT04080284

COMPLETED Phase 4

Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

NCT04197869

COMPLETED NA

Effect of Daily Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome

NCT04169776

COMPLETED NA

Personalized Trial for Chronic Lower Back Pain

NCT04203888

COMPLETED NA

Financial Incentives to Improve Medication Adherence

NCT04191876

COMPLETED NA

Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)

NCT04179721

COMPLETED NA

Diabetes Management Program for Hispanic/Latino

NCT03960424

TERMINATED NA

Transcutaneous Spinal and Peripheral Stimulation and Wrist Robotic Therapy for Patients With Spastic Stroke

NCT04113525

TERMINATED

Mechanism of Weight Loss After Endoscopic and Laparoscopic Sleeve Procedures

NCT04006002

TERMINATED NA

Porcine Xenograft Versus Second Intention Healing

NCT03931746

COMPLETED NA

To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty

NCT03952546

COMPLETED

Effect of Nusinersen on Adults With Spinal Muscular Atrophy

NCT03878030

COMPLETED Phase 3

PICO Negative Pressure Wound Therapy in Obese Women Undergoing Elective Cesarean Delivery.

NCT03414762

TERMINATED NA

Long-term Cardiac Monitoring in Epilepsy

NCT03955432

COMPLETED NA

Transcutaneous VNS to Treat Pediatric IBD

NCT03863704

COMPLETED NA

Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)

NCT03814824

COMPLETED NA

A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander

NCT03814902

COMPLETED NA

Northwell Health Visits: A Family Connects Pilot Implementation at Northwell Health

NCT03887910

COMPLETED

Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias

NCT03831516

COMPLETED NA

Recovery Support for Bladder Cancer Patients and Caregivers

NCT04055311

TERMINATED

Imaging Modalities for Pancreatic Collections

NCT03556501

COMPLETED Phase 2

Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke

NCT03592745

COMPLETED NA

Enhancing and Scaling a High-Touch Home-based Primary Care Program

NCT03545698

TERMINATED Phase 1

Effects of Probiotic on Inflammation and Microbiota in Patients With NASH

NCT03511365

TERMINATED NA

Boost rTMS for Auditory Verbal Hallucinations

NCT03544333

COMPLETED NA

Safety and Efficacy of Sonohysterosalpingography for the Evaluation of Infertility

NCT03234569

COMPLETED

Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities

NCT03387397

COMPLETED NA

Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease

NCT03383627

TERMINATED NA

30 Day Rehospitalization Risk in Hemodialysis Patients

NCT02553564

COMPLETED NA

Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain

NCT02822989

COMPLETED Early Phase 1

Evaluating Neuromuscular Stimulation for Restoring Hand Movements

NCT03385005

TERMINATED Phase 4

Serratus Plane Block for Postoperative Pain Control

NCT02865928

COMPLETED

The CAROLE (CArdiac Related Oncologic Late Effects) Study

NCT03235427

TERMINATED Phase 2

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

NCT03145480

COMPLETED Phase 2

Lanreotide in the Treatment of Small Bowel Motility Disorders

NCT03012594

COMPLETED NA

Volumetric Bladder Ultrasound Training for Pediatric Residents

NCT03129789

← Previous Page 4 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 30
Phase 3 12
Phase 4 26

What is open in the Northwell Health pipeline

81 recruiting of 370 indexed (22% open); 209 completed (56%).

Phase mix: 38 late (III/IV) vs 80 early (I/II) (early-phase heavy).

Top condition: Schizophrenia (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwell Health: open-pipeline peers nationwide

Peers matched on 370 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%5%10%15%20%25% Total trials Recruiting share Northwell HealthUniversity of California, IrvineUNC Lineberger Comprehensive Cancer CenterRoswell Park Cancer InstituteNew York State Psychiatric InstituteSt. Jude Children's Research HospitalRegeneron PharmaceuticalsAtriCureUniversity of Colorado, Boulder
Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 370 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

What to do with this Northwell Health page

370 registered trials is a research-attention snapshot, not an endorsement of Northwell Health or any single study.

  • 81 of Northwell Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Schizophrenia is the condition Northwell Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Northwell Health pipeline card: 370 registered trials from official public datasets.Report a data error.